Skip to main navigation Skip to search Skip to main content

An exploratory Phase 2, randomized, double-blind, placebo-controlled, parallel design study to evaluate the safety , tolerability, and pharmacodynamics of AZD1722 in CKD patients with type 2 diabetes mellitus and albuminuria

Project: Research

Project Details

StatusFinished
Effective start/end date07/18/13 → 12/31/15

Funding

  • Medpace Inc: $5,000.00